Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity
US5409699A · kind A · utility
9Cited by
13References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1991 |
| Grant date | Apr 25, 1995 |
| Priority date | — |
| Expiry date | Jul 19, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is a pharmaceutical composition containing a glycosylated protein having human tissue type plasminogen activator activity of at least 1.4 MU/ml, citrate, and at least one of a number of various compounds. The composition has a pH ranging from 4.5 to 9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.